Fri, Aug 2, 1:06 PM (88 days ago)
Stereotaxis, Inc. (NYSE: STXS) has completed the acquisition of Access Point Technologies EP, Inc. (APT), a Minnesota-based company specializing in diagnostic catheters for cardiac ablation procedures. The acquisition was finalized on July 31, 2024, following a Share Purchase Agreement dated May 11, 2024. As part of the transaction, Stereotaxis issued 1,486,620 shares of its common stock as Upfront Stock Consideration. The issuance was conducted under the private offering exemption of Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D, making the shares restricted securities under Rule 144. This acquisition aims to enhance Stereotaxis' product portfolio and market reach in the global cardiac ablation market.